Iradimed corporation (IRMD)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Operating activities:
Net income

9,630

6,303

499

7,214

-

-

-

Net income

-

-

-

-

7,529

2,050

1,936

Adjustments to reconcile net income to net cash provided by operating activities:
Change in allowance for doubtful accounts

31

15

-7

12

3

-108

-

Change in provision for excess and obsolete inventory

48

111

69

94

51

62

-

Depreciation and amortization

1,242

1,105

1,308

955

807

149

139

Write-off of non-trade accounts receivable

-

-

205

-

-

-

-

Excess tax benefit on the exercise of stock options

-

-

-

-603

-1,728

-

-

Excess tax benefit on the exercise of stock options

-

-

-

-

-

165

-

Stock-based compensation

1,854

1,764

2,454

1,841

1,220

724

271

Deferred income taxes, net

596

144

150

570

16

167

48

Impairment of intangible assets

-

-

-

-

55

-

-

Loss on maturities of investments

10

-28

-6

-83

-3

7

-

Changes in operating assets and liabilities:
Accounts receivable

3,114

446

201

-75

1,906

-130

396

Inventory

-123

121

334

1,483

308

847

-45

Prepaid expenses and other current assets

487

407

1,161

702

615

154

40

Other assets

171

-65

13

117

113

15

4

Accounts payable

149

34

-523

1

376

201

19

Accrued payroll and benefits

363

289

477

-252

43

589

114

Other accrued taxes

463

23

-9

88

-35

-14

60

Warranty reserve

7

13

19

6

6

15

-0

Deferred revenue

700

-5

944

1,723

-

-

-

Deferred revenue

-

-

-

-

501

186

-126

Other current liability

-

-0

-12

120

-

-

-

Prepaid income taxes

-3

-1,252

-155

917

1,775

-48

-494

Other

-0

-

-

-

-

-5

-

Net cash provided by operating activities

10,232

7,376

3,415

9,406

7,649

-

-

Investing activities:
Net cash (used in) provided by operating activities

-

-

-

-

-

2,585

1,474

Purchases of investments

-

1,124

2,693

4,992

-

7,951

4

Proceeds from maturity of investments

3,687

2,905

2,495

-

-

-

-

Proceeds from maturity of investments

-

-

-

-4,575

-253

-255

-

Purchases of property and equipment

368

228

775

780

298

583

163

Capitalized intangible assets

117

36

49

743

16

22

28

Net cash (used in) provided by investing activities

3,201

1,515

-1,023

-1,941

-61

-8,302

-196

Financing activities:
Proceeds from stock option and warrant exercises

2,493

1,239

76

247

597

105

-

Taxes paid for the net share settlement of equity awards

473

309

158

-

-

-

-

Income tax benefits credited to equity

-

-

-

603

1,728

165

-

Purchases of treasury stock

-

-

1,818

9,969

-

-

-

Net cash provided by financing activities

2,020

929

-1,900

-9,118

2,326

-

-

Net increase in cash and cash equivalents

15,454

9,821

492

-1,654

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

9,913

-

-

Repayment of officer note payable

-

-

-

-

-

6

513

Proceeds from the issuance of common stock pursuant to initial public offering

-

-

-

-

-

14,490

-

Payment of initial public offering costs

-

-

-

-

-

2,044

-

Net cash used in financing activities

-

-

-

-

-

12,709

-513

Net decrease in cash and cash equivalents

-

-

-

-

-

6,992

764

Supplemental disclosure of cash flow information:
Cash paid for income taxes

12

1,375

1,205

3,392

2,702

-

-

Right-of-use asset recognized in exchange for new lease obligation

3,182

-

-

-

-

-

-

Operating and short-term lease payments recorded within cash flow from operating activities

428

418

409

-

-

-

-

Cash paid for income taxes

-

-

-

-

-

1,182

-

Cash paid for income taxes

-

-

-

-

-

-

1,390